Hansa Biopharma AB (HNSBF)
2.91
0.00 (0.00%)
USD |
OTCM |
Dec 15, 16:00
Hansa Biopharma Total Liabilities (Quarterly): 138.42M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Orexo AB | -- |
| Vivesto AB | 1.748M |
| BioInvent International AB | 10.93M |
| BioArctic AB | 67.18M |
| Camurus AB | 54.23M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 78.80M |
| Shareholders Equity (Quarterly) | -59.62M |
| Debt to Equity Ratio | -1.648 |
| Current Ratio | 1.106 |
| Net Debt Paydown Yield | -0.50% |